Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $8.5569 per ML under NDC 00378705567. Its NADAC has been published 254 times since Aug 18, 2021.
Strength
15 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378705567
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BEPOTASTINE BESILATEApproval Type
Generic (ANDA)
FDA Application
ANDA206220On Market Since
5/28/2021
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 254 times since Aug 18, 2021, and over the history we have for it it has declined 76.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.5569 per ML |
|---|---|
| All-time high | $36.0376 (Dec 15, 2021) |
| All-time low | $8.5569 (Jun 17, 2026) |
| 52-week high | $17.6086 |
| 52-week low | $8.5569 |
| Median price | $18.8238 |
| Average price | $20.6677 |
| Largest weekly change | -29.4% (May 18, 2022) |
| Weeks tracked | 254 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Mylan Pharmaceuticals Inc., is $8.5569 per ML (NDC 00378705567), effective Jun 24, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 76.3%. It has been tracked across 254 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $8.5569 (Jun 17, 2026) to a high of $36.0376 (Dec 15, 2021), with a median of $18.8238 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BEPOTASTINE 1.5% EYE DROP, but none are currently priced below it.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 00378705567) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification